Pharma won’t benefit from digital innovation without anticipating its challenges

Healthcare is in the midst of a digital shift. Artificial intelligence offers physicians providers an new resource when making decisions, new data streams promise hyper-personalized treatments and digital therapeutics evangelists see are hawking the novel treatments as a companion, or even a replacement, to traditional biologic treatments. All in all, it’s a future that hopes to empower the individual while streamlining care and cutting costs — but only if pharma and other established players can identify its challenges and properly embrace what’s to come.